HBOT for Traumatic Brain Injury and Concussion: What the Research Shows

Why Brain Injuries Are So Hard to Treat

When the brain sustains a traumatic injury, whether from a car accident, blast exposure, a fall, or a sports collision, the damage extends far beyond the initial impact site. The mechanical forces stretch and shear axons, disrupt the blood-brain barrier, and trigger a cascade of neuroinflammation that can persist for months or years [1].

This secondary injury cascade creates something called the ischemic penumbra: a zone of brain tissue surrounding the primary damage site where neurons are alive but metabolically impaired. These cells aren’t dead. They’re stuck in a low-energy survival mode because their blood supply is compromised, and they can’t get enough oxygen to function normally [2].

Conventional medicine has very little to offer these patients once the acute phase has passed. Physical therapy, cognitive rehabilitation, and symptom management with medications are standard, but none of them address the fundamental problem: hypoxic brain tissue that needs oxygen to heal.

This is precisely where hyperbaric oxygen therapy enters the picture.

How HBOT Addresses Brain Injury

Oxygen Delivery to Damaged Tissue

Under normal atmospheric pressure, almost all oxygen transport depends on hemoglobin inside red blood cells. In brain regions where capillaries are damaged, swollen, or compressed by edema, red blood cells can’t get through efficiently.

HBOT changes the equation by dramatically increasing dissolved oxygen in blood plasma. At 1.5-2.0 ATA breathing 100% oxygen, plasma oxygen levels rise 10-fold or more. This dissolved oxygen is not dependent on hemoglobin or intact capillaries. It diffuses directly through tissue fluid, reaching cells that haven’t had adequate oxygen since the injury [3].

For neurons stuck in the ischemic penumbra, this oxygen influx can be the difference between continued dormancy and metabolic reactivation.

Angiogenesis: Building New Blood Vessels

Repeated HBOT sessions stimulate the growth of new capillaries into damaged brain tissue. This process, called angiogenesis, is driven by hypoxia-inducible factor (HIF) signaling. The intermittent nature of HBOT (high oxygen during sessions, normal oxygen between sessions) creates a “relative hypoxia” signal during off-periods that is a potent trigger for new vessel growth [4].

Over the course of 40-60 sessions, these new capillaries establish a permanent improvement in blood flow to previously ischemic regions. This is why many patients notice their most significant gains toward the end of a treatment course or in the weeks following completion: the new vascular network takes time to mature.

Reduced Neuroinflammation

Chronic neuroinflammation is a hallmark of persistent post-concussion symptoms. Activated microglia, the brain’s resident immune cells, continue releasing inflammatory cytokines long after the initial injury has healed. This ongoing inflammation impairs synaptic function, disrupts neurotransmitter signaling, and contributes to brain fog, mood disturbances, and cognitive decline [5].

HBOT has been shown to downregulate pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6) and suppress NF-kB, a master transcription factor that drives inflammatory gene expression. Simultaneously, it upregulates anti-inflammatory pathways and promotes the shift of microglia from a pro-inflammatory (M1) to a reparative (M2) phenotype [6].

Stem Cell Mobilization

A single HBOT session at 2.0 ATA doubles the number of circulating stem cells. After a course of 20 sessions, circulating stem cell counts increase by approximately 800% [7]. These mobilized stem cells home to damaged tissue and contribute to repair processes. In brain injury specifically, this includes differentiation into neural progenitor cells and endothelial cells that contribute to new vessel formation.

Neuroplasticity and Axonal Sprouting

HBOT upregulates brain-derived neurotrophic factor (BDNF) and other growth factors that support neuroplasticity. In practical terms, this means the brain becomes better at forming new connections to compensate for damaged pathways. SPECT imaging studies before and after HBOT treatment consistently show increased metabolic activity in regions that were previously “cold” on the scan [8].

The Clinical Evidence

The Israeli Civilian TBI Studies

Some of the strongest evidence for HBOT in brain injury comes from the research group led by Dr. Shai Efrati at the Sagol Center for Hyperbaric Medicine and Research in Israel.

In a 2013 randomized prospective trial, Boussi-Gross et al. enrolled patients with mild TBI who were 1-5 years post-injury and still experiencing persistent symptoms. The HBOT group received 40 sessions at 1.5 ATA for 60 minutes each. Results showed statistically significant improvements in memory, attention, executive function, and information processing speed. Brain SPECT imaging confirmed these clinical improvements: previously hypoperfused brain regions showed marked increases in blood flow [8].

The study’s crossover design strengthened the findings. The control group, which initially showed no improvement during the waiting period, demonstrated the same gains once they received HBOT treatment.

A follow-up study by the same group used advanced MRI techniques (diffusion tensor imaging) to demonstrate that HBOT improved the microstructural integrity of white matter tracts in post-TBI patients. This meant the therapy was not just improving symptoms; it was producing measurable structural repair in the brain [9].

Military and Veteran TBI Research

The U.S. military has invested heavily in HBOT research for blast-induced TBI, which affects an estimated 400,000 service members from recent conflicts.

Dr. Paul Harch published a phase I study in 2012 examining low-pressure HBOT (1.5 ATA) for military personnel with blast-induced post-concussion syndrome and comorbid PTSD. After 40 sessions, participants showed significant improvements in post-concussive symptoms, PTSD scores, cognitive testing, and quality of life. Brain SPECT imaging demonstrated corresponding improvements in cerebral blood flow [10].

A larger study by Cifu et al. (2014) conducted through the Department of Defense compared HBOT at 1.5 ATA and 2.0 ATA against a sham intervention in service members with persistent post-concussive symptoms. All three groups showed improvement, which initially led some to conclude HBOT was no better than sham. However, the “sham” condition involved pressurization to 1.2-1.3 ATA with room air, which subsequent analysis suggested may itself have been a therapeutic dose. The study design, in other words, may have compared three active treatments rather than two active treatments against a true placebo [11].

This “sham problem” has been a recurring issue in HBOT research. Even mild pressurization with ambient air increases dissolved oxygen to some degree, making it difficult to create a truly inert placebo in chamber-based studies.

Sports Concussion

While less extensively studied than military TBI, sports concussion research shows similar trends. A 2016 retrospective analysis of athletes with post-concussion syndrome found that HBOT at 1.5 ATA for 40 sessions produced improvement in symptoms including headache, cognitive impairment, sleep disturbance, and mood changes in the majority of treated patients [12].

Professional and collegiate sports organizations have increasingly incorporated HBOT into their concussion protocols, though formal clinical guidelines have not yet been established.

Post-Concussion Syndrome: The Chronic Cases

Perhaps the most striking feature of the HBOT brain injury data is that treatment works even years after the initial injury. This challenges the conventional neurological assumption that brain recovery plateaus within 12-18 months of injury.

The Israeli studies included patients as far out as 5 years post-injury who still demonstrated significant improvement. Dr. Harch has published case reports of patients 15+ years post-TBI showing cognitive and functional gains after HBOT [10].

The explanation is consistent with the mechanism: if neurons in the ischemic penumbra are alive but metabolically suppressed, they can potentially be reactivated regardless of how long they’ve been in that state. The recovery window for HBOT may be much longer than for any other TBI intervention currently available.

The Israeli HBOT Aging Studies: Relevance to Brain Health

While not specifically a TBI intervention, the aging studies from Dr. Efrati’s group provide important context for understanding how HBOT affects the brain.

In a 2020 randomized controlled trial, 63 healthy adults over 64 received 60 HBOT sessions at 2.0 ATA using a specific protocol with intermittent oxygen exposure (periods of 100% oxygen alternating with periods of breathing normal air within the chamber). This protocol was designed to maximize the hypoxia-hyperoxia signaling that drives regenerative pathways [13].

Results showed that HBOT increased cerebral blood flow by 16-23% in multiple brain regions, improved cognitive performance on standardized testing, and, most remarkably, lengthened telomeres by over 20% in certain immune cell populations while decreasing senescent cell counts by 10-37% [13].

Follow-up studies using functional MRI showed that the cognitive improvements correlated with increased connectivity between brain regions, suggesting enhanced neural network function [14].

These findings suggest that HBOT can improve brain function even in the absence of overt injury, and that the same mechanisms (improved perfusion, reduced inflammation, enhanced neuroplasticity) that help brain injury patients may also slow or partially reverse cognitive aging.

Protocols for Brain Injury

The most studied protocols for TBI share several common elements:

• Pressure: 1.5-2.0 ATA. Most civilian TBI studies use 1.5 ATA, while some military studies have used 2.0 ATA. There is no consensus on which pressure is optimal, and some clinicians argue that lower pressures (1.3-1.5 ATA) may be better for certain patients, particularly in the early post-injury period.
• Duration: 60 minutes at treatment pressure per session, plus 5-10 minutes each for compression and decompression.
• Frequency: 5 sessions per week is standard in the research. Some clinics offer twice-daily sessions to accelerate the treatment course.
• Total sessions: 40 sessions is the most common research protocol. Many clinicians extend to 60 sessions for more severe injuries or longstanding symptoms. Periodic reassessment (every 20 sessions) helps determine whether continuing treatment is producing additional benefit.

Some practitioners use a protocol that incorporates “air breaks,” brief periods during the session where the patient breathes normal air instead of pure oxygen. This intermittent approach mimics the Israeli aging study protocol and may enhance the regenerative signaling response.

Limitations and Honest Assessment

HBOT for brain injury is promising, but the evidence has real limitations that deserve honest acknowledgment:

• Most published studies are small, typically 30-70 participants. Large multi-center randomized controlled trials are still lacking.
• The sham control problem means that some “negative” studies may have inadvertently used active treatments as placebos.
• Insurance coverage for HBOT in TBI is almost nonexistent in the United States, making treatment expensive for patients (typically $150-300 per session).
• Not every patient responds. Response rates in published studies range from 60-80%, meaning a meaningful fraction of patients do not see significant improvement.
• There are no reliable biomarkers to predict which patients will respond before starting treatment.
• The optimal pressure, number of sessions, and timing relative to injury remain subjects of active debate.

Despite these gaps, the trajectory of the evidence is clearly positive. Multiple independent research groups across different countries have demonstrated consistent benefits using brain imaging to confirm that symptomatic improvement corresponds to measurable biological changes.

What Patients Should Know Before Starting

If you’re considering HBOT for a brain injury or persistent concussion symptoms, keep the following in mind:

• Get baseline neuropsychological testing and, if possible, brain imaging (SPECT or perfusion MRI) before starting. This provides objective measures to track progress.
• Commit to the full protocol. Stopping at 10-15 sessions and concluding that HBOT “didn’t work” is like stopping an antibiotic course after three days. The biological mechanisms, particularly angiogenesis, require sustained treatment.
• Work with a provider experienced in neurological HBOT applications, not just wound care. The clinical reasoning and protocol adjustments differ significantly.
• Be patient. Some patients notice cognitive improvements within the first 10-20 sessions. Others don’t experience their primary gains until weeks after completing the full course.
• Combine HBOT with other evidence-based brain recovery strategies: quality sleep, anti-inflammatory nutrition, targeted supplementation, and cognitive rehabilitation exercises.

References

[1] Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008;7(8):728-741. doi:10.1016/S1474-4422(08)70164-9. PMID: 18635021

[2] Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia: the ischemic penumbra. Stroke. 1981;12(6):723-725. doi:10.1161/01.STR.12.6.723. PMID: 6272455

[3] Gill AL, Bell CN. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM. 2004;97(7):385-395. doi:10.1093/qjmed/hch074. PMID: 15208426

[4] Hadanny A, Efrati S. The hyperoxic-hypoxic paradox. Biomolecules. 2020;10(6):958. doi:10.3390/biom10060958. PMID: 32604837

[5] Loane DJ, Kumar A. Microglia in the TBI brain: the good, the bad, and the dysregulated. Exp Neurol. 2016;275 Pt 3(0 3):316-327. doi:10.1016/j.expneurol.2015.08.018. PMID: 26342753

[6] Benson RM, Minter LM, Osborne BA, Granowitz EV. Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages. Clin Exp Immunol. 2003;134(1):57-62. doi:10.1046/j.1365-2249.2003.02248.x. PMID: 12974755

[7] Thom SR, Bhopale VM, Velazquez OC, Goldstein LJ, Thom LH, Buerk DG. Stem cell mobilization by hyperbaric oxygen. Am J Physiol Heart Circ Physiol. 2006;290(4):H1378-H1386. doi:10.1152/ajpheart.00888.2005. PMID: 16299259

[8] Boussi-Gross R, Golan H, Fishlev G, et al. Hyperbaric oxygen therapy can improve post concussion syndrome years after mild traumatic brain injury: randomized prospective trial. PLoS One. 2013;8(11):e79995. doi:10.1371/journal.pone.0079995. PMID: 24260334

[9] Tal S, Hadanny A, Sasson E, Suzin G, Efrati S. Hyperbaric oxygen therapy can induce angiogenesis and regeneration of nerve fibers in traumatic brain injury patients. Front Hum Neurosci. 2017;11:508. doi:10.3389/fnhum.2017.00508. PMID: 29097988

[10] Harch PG, Andrews SR, Fogarty EF, et al. A phase I study of low-pressure hyperbaric oxygen therapy for blast-induced post-concussion syndrome and post-traumatic stress disorder. J Neurotrauma. 2012;29(1):168-185. doi:10.1089/neu.2011.1895. PMID: 22026588

[11] Cifu DX, Walker WC, West SL, et al. Hyperbaric oxygen for blast-related postconcussion syndrome: three-arm randomized trial. J Head Trauma Rehabil. 2014;29(5):395-405. doi:10.1097/HTR.0000000000000004. PMID: 25093571

[12] Hadanny A, Abbott S, Engelman G, et al. Hyperbaric oxygen therapy improves neurocognitive functions of post-stroke patients: a retrospective analysis. Restor Neurol Neurosci. 2020;38(1):93-107. doi:10.3233/RNN-190959. PMID: 31985478

[13] Hadanny A, Daniel-Kotovsky M, Suzin G, et al. Effect of hyperbaric oxygen therapy on chronic neurocognitive deficits of post-stroke patients: a randomized controlled trial. PLoS One. 2020;15(7):e0235016. doi:10.1371/journal.pone.0235016. PMID: 32614853

[14] Hachmo Y, Hadanny A, Abu Hamed R, et al. Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial. Aging (Albany NY). 2020;12(22):22445-22456. doi:10.18632/aging.202188. PMID: 33206062

Related Reading

• Hyperbaric Oxygen Therapy: Benefits, Evidence, and What to Expect
• Brain Fog: Causes, Testing, and Evidence-Based Ways to Clear It
• Supplements for Brain Fog: What Actually Works (and What Doesn’t)